Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Search Results
Search Results 41 – 60 of 113
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Periconception, Antepartum, and Postpartum Periods
… should discuss HIV pre-exposure prophylaxis (PrEP) with all sexually active people without HIV, including those who are … suppression is associated with virtually no risk of HIV sexual transmission (see Reproductive Options When One or … Explain that PrEP does not protect against other sexually transmitted infections (STIs). Condom use is …
https://clinicalinfo.hiv.gov/node/11175
Emtricitabina / Alafenamida de tenofovir
… al riesgo de esa infección por medio de las relaciones sexuales. La etiqueta del medicamento aprobada por la FDA … siempre junto con prácticas seguras durante las relaciones sexuales, por ejemplo, el uso de condones, para reducir el riesgo de contraer otras infecciones de transmisión sexual . Descovy contiene dos medicamentos diferentes: …
https://clinicalinfo.hiv.gov/drugs/emtricitabina-alafenamida-de-tenofovir/paciente
MK-8527
… and efficacy of once-monthly oral MK-8527 as HIV PrEP in sexually active women and adolescent girls in sub-Saharan Africa. Study Population : Participants are sexually active women and adolescent girls (16 to 30 years … and efficacy of once-monthly oral MK-8527 as HIV PrEP in sexually active adults and adolescents who could benefit …
https://clinicalinfo.hiv.gov/node/13456
Immunizations for Preventable Diseases in Adults and Adolescents With HIV
… 7 days after percutaneous exposure and up to 14 days after sexual exposure). Evidence Summary All family members and sexual contacts of people with chronic HBV infection should be tested, and all susceptible household and sexual contacts should receive HepB vaccination regardless …
https://clinicalinfo.hiv.gov/node/9466
Tenofovir-Based Microbicides
… investigational products that are being studied to prevent sexual transmission of HIV . 4-11  They have also been … are used close to where HIV might enter the body during sexual activities – either the vagina or rectum. 12,13 …
https://clinicalinfo.hiv.gov/drugs/microbicidas-base-de-tenofovir/paciente
Día Nacional de Concientización sobre el VIH/SIDA en Hombres Homosexuales
… de Concientización sobre el VIH/SIDA entre hombres homosexuales (NGMHAAD, por sus siglas en inglés), que se celebra … desproporcionado de la epidemia del VIH en los hombres homosexuales y bisexuales en los Estados Unidos. Los hombres homosexuales, … de Concientización sobre el VIH/SIDA en Hombres Homosexuales …
https://clinicalinfo.hiv.gov/news/dia-nacional-de-concientizacion-sobre-el-vihsida-en-hombres-homosexuales
National Gay Men’s HIV/AIDS Awareness Day
… disproportionate impact of the HIV epidemic on gay and bisexual men in the United States. Gay, bisexual, and other men who report male-to-male sexual contact are the population most affected by HIV in …
https://clinicalinfo.hiv.gov/news/dia-nacional-de-concientizacion-sobre-el-vihsida-en-hombres-homosexuales
National HIV Testing Day
… since their last HIV test or having sex with someone whose sexual history they don’t know – should get tested annually. Some sexually active gay and bisexual men may benefit from more frequent testing (e.g., …
https://clinicalinfo.hiv.gov/news/dia-nacional-de-la-prueba-del-vih-2
Appendix B: Web-Based Resources for Treating and Preventing HIV
… HIV for persons exposed: In an occupational setting Through sexual contact or nonsterile injection of drugs U.S. … HIV for people who may be at high risk of exposure due to sexual contact or sharing of nonsterile equipment to inject …
https://clinicalinfo.hiv.gov/node/9474
Baseline Evaluation
… ). In addition, other tests (including screening tests for sexually transmitted infections, opportunistic infections, … after ART initiation to review test results. Screening for sexually transmitted infections should, ideally, occur at … include a discussion of risk reduction and disclosure to sexual and/or needle-sharing partners, especially with …
https://clinicalinfo.hiv.gov/node/9485
Lenacapavir
… such as using condoms, to reduce the risk of getting other sexually transmitted infections .   For more information on …
https://clinicalinfo.hiv.gov/drugs/lenacapavir/patient
MK-8527
… and efficacy of once-monthly oral MK-8527 as HIV PrEP in sexually active women and adolescent girls in sub-Saharan … and efficacy of once-monthly oral MK-8527 as HIV PrEP in sexually active adults and adolescents who could benefit …
https://clinicalinfo.hiv.gov/drugs/mk-8527/paciente
Introduction
… in children with HIV, including adolescents with sexual maturity ratings (SMRs; formerly Tanner Staging) 1 to … infants, children, and adolescents in early to mid-puberty (sexual maturity rating [SMR] 1–3) with HIV. Panel Members … from the Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine participate as nonvoting, ex officio …
https://clinicalinfo.hiv.gov/node/9226
Hepatitis C Virus Infection
… those with HIV, multiple sex partners, or sexually transmitted infections—should be advised to use … or sharing of potentially contaminated personal items, and sexual exposure. 11,12 Before 1992, blood transfusion was a … acquisition included noninjection drug use and a history of sexually transmitted infections. 50 Clinical Manifestations …
https://clinicalinfo.hiv.gov/node/9265
Patrocinadores
… por el VIH/SIDA y otras enfermedades de transmisión sexual. El Instituto también apoya estudios de investigación … para la Prevención de las Enfermedades de Transmisión Sexual, la Infección por el VIH y la Tuberculosis (National …
https://clinicalinfo.hiv.gov/patrocinadores
MK-8527
… mes como PrEP para el VIH en mujeres y niñas adolescentes sexualmente activas en África al Sur del Sahara Nombres del … vez por mes como PrEP para el VIH en adultos y adolescentes sexualmente activos que podrían beneficiarse de esa …
https://clinicalinfo.hiv.gov/drugs/mk-8527/paciente
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
… potential who are trying to conceive or who are sexually active and not using effective contraception. Now, … individuals who are not planning to conceive but who are sexually active and not using contraception, consider a … potential who are planning to become pregnant or who are sexually active and not using effective contraception Refer …
https://clinicalinfo.hiv.gov/node/9407
Emtricitabine / Tenofovir Disoproxil Fumarate
… such as using condoms, to reduce the risk of getting other sexually transmitted infections . Truvada contains two …
https://clinicalinfo.hiv.gov/drugs/emtricitabina-fumarato-de-disoproxilo-de-tenofovir/paciente
Antiretroviral Drug Resistance and Resistance Testing in Pregnancy
… Transmitted INSTI resistance is suspected (e.g., a prior sexual partner was on INSTI therapy and not virologically … or PrEP that included an INSTI, or when a patient has had a sexual partner on INSTI therapy who was not virologically …
https://clinicalinfo.hiv.gov/node/9461
Cytomegalovirus Disease
… several ways, including through breastfeeding, perinatally, sexually, viral shedding in bodily fluids (saliva, urine, or … to CMV among adults with HIV, but condoms may reduce sexual transmission of CMV. 31,32 Preventing Disease … . Drew LW. Condoms and the transmission of cytomegalovirus. Sexually Transmitted Diseases . 1998;25(9):481-482. …
https://clinicalinfo.hiv.gov/node/9174

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 1
  • Página 2
  • Página actual 3
  • Página 4
  • Página 5
  • Página 6
  • Siguiente página ›
  • Última página »

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.